MedTrace Logo

Atrial Fibrillation in Turkey: Epidemiologic Registry-2

NCT02354456 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 4100

Last updated 2016-01-21

No results posted yet for this study

Summary

Atrial fibrillation (AF) is one of the most common cause of preventable ischemic stroke and associated with increased cardiovascular morbidity and mortality. Our previous AFTER study demonstrated the general epidemiological data about the patients with valvular and nonvalvular AF in Turkey. However, data is lacking about the use of new oral anticoagulants (NOACs), time in therapeutic INR range (TTR) in vitamin K antagonist users and AF management modality in our country. In this multicenter trial the investigators aimed to analyze, follow and evaluate the epidemiological data in non-valvular AF patients.

Conditions

Sponsors & Collaborators

  • Dicle University

    lead OTHER

Principal Investigators

  • Faruk Ertas, Assoc. Prof. · Dicle University School of Medicine

Eligibility

Min Age
18 Years
Max Age
95 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-01-31
Primary Completion
2016-01-31
Completion
2016-07-31

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02354456 on ClinicalTrials.gov